Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer (NCT04464226)
An Open-label, Single Arm, Roll-over Study to Provide Continued Treatment With Darolutamide in Participants Who Were Enrolled in Previous Bayer Sponsored Studies
🩺 Plain-English Summary (8th-Grade Level)
The aim of this study is to provide darolutamide treatment to patients who participated in a previous study with darolutamide supported by Bayer and the treating doctor considers that the continuation of the treatment with darolutamide to be beneficial. Patients will be carried over from the previous studies and continue in this study with darolutamide treatment on the same dosage. They will also return to the study centers for doctor's visits as often as they did in the previous study.
Who can join: Review the eligibility criteria below.
Location: Urology Centers of Alabama, PC - Homewood — Homewood, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (335 Sites)
Showing the first 25 of 335 sites.
- Urology Centers of Alabama, PC - Homewood — Homewood, Alabama
- Ironwood Cancer and Research Centers - Chandler I — Chandler, Arizona
- Tower Urology — Los Angeles, California
- Stanford Cancer Center Palo Alto — Palo Alto, California
- San Diego Clinical Trials — San Diego, California
- TOI Clinical Research — Whittier, California
- Rocky Mountain Regional VA Medical Center - Oncology — Aurora, Colorado
- The Urology Center Of Colorado — Denver, Colorado
- Boca Raton Regional Hospital - Oncology — Boca Raton, Florida
- Jesse Brown VA Medical Center - Cardiology — Chicago, Illinois
- Illinois CancerCare - Peoria — Peoria, Illinois
- Norton Cancer Institute - Downtown — Louisville, Kentucky
- Chesapeake Urology Associates - Towson — Baltimore, Maryland
- Johns Hopkins Hospital - Pulmonology — Baltimore, Maryland
- TidalHealth Peninsula Regional, Inc. - Oncology — Salisbury, Maryland
- Henry Ford Hospital - OB/GYN — Detroit, Michigan
- St. Vincent Regional Hospital - Oncology — Billings, Montana
- XCancer Omaha — Omaha, Nebraska
- New Jersey Urology - Voorhees — Voorhees Township, New Jersey
- New Mexico Cancer Center - Albuquerque — Albuquerque, New Mexico
- URMC Wilmot Cancer Center — Rochester, New York
- New York Cancer & Blood Specialists - Eastchester — The Bronx, New York
- Montefiore Einstein Center for Cancer Care - Tower at Montefiore Medical Park — The Bronx, New York
- Gabrail Cancer Center — Canton, Ohio
- The Urology Group - Norwood Surgery Center — Cincinnati, Ohio
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cancer
- Ovarian Tissue Cryopreservation in Children — Rochester, Minnesota
- A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study — Aurora, Colorado
- Ex Onc SLED: A Study Utilizing A Weighted Sled for Horizontal Resistance Training — Pittsburgh, Pennsylvania
- An Internet-based Program to Help Cancer Survivors Manage Pain — Fort Smith, Arkansas
- Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer Survivors — Toronto, Ontario
- Researching the Effect of Aerobic Exercise on Cancer — Los Angeles, California
Explore by condition: All Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.